Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-06

Clinical Trial Update: YKL-40 and Complications in Type 2 Diabetes

View source ↗

Summary

Completed clinical trial from National Taiwan University Hospital evaluating the association between YKL-40 and complications in Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED